CBT PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

CBT ▲ +3.47% at T+20d

SHORT call ✗ call lost -3.47% · α vs SPY -0.69% · entry $82.41 → $85.27

Next anchor: T+60d in 7w

Currently $84.39 · -2.40% from $82.41 entry (call sign-flipped)

Entry anchored
May 5, 03:59 PM ET
via Databento tick

T+1d

0.00%

call 0.00% · α -0.33%

$82.41

settled 5w ago

T+5d

+2.57%

call -2.57% · α -1.44%

$84.53

settled 29d ago

T+20d

+3.47%

call -3.47% · α -0.69%

$85.27

settled 7d ago

T+60d

—

call — · α —

—

in 7w

Price Chart

Loading chart...

Executive Summary

Cabot reported Q2 fiscal 2026 revenue of $904M (down 3.4% YoY) and GAAP EPS of $1.27 (down 25% YoY), both declining from the prior-year quarter. Adjusted EPS of $1.61 also fell 15% YoY, driven by lower gross profit per ton in Reinforcement Materials and competitive pressures, partially offset by strong Performance Chemicals results. The company reaffirmed its full-year Adjusted EPS guidance of $6.00-$6.50 and announced a 5% dividend increase and asset rationalization plans.

Key Financial Metrics

Free Cash Flow

$32.0M

Gross Margin

23.23%

Actionable Insight

The YoY declines in revenue and EPS, despite reaffirmed guidance, suggest weakening fundamentals. Monitor demand trends in Reinforcement Materials and the impact of Middle East disruptions on near-term demand. The dividend increase and share repurchases signal management confidence, but the stock may face headwinds from margin compression and competitive intensity.

Key Facts

Q2 2026 revenue: $904M vs $936M in Q2 2025 (-3.4% YoY)
GAAP EPS: $1.27 vs $1.69 in Q2 2025 (-25% YoY)
Adjusted EPS: $1.61 vs $1.90 in Q2 2025 (-15% YoY)
Reaffirmed FY2026 Adjusted EPS guidance: $6.00-$6.50
Reinforcement Materials EBIT declined 29% YoY to $93M; Performance Chemicals EBIT up 18% YoY to $59M
Announced 5% dividend increase (annualized from $1.80 to $1.89) and plans to close manufacturing facilities in South America and Europe

Financial Impact

Revenue declined ~$32M YoY; GAAP net income fell $26M; certain items totaled $0.34 per share after tax.

revenueepsebit

Risk Factors

Further deterioration in tire customer demand and competitive pricing in Asia Pacific
Geopolitical uncertainty from Middle East conflict affecting demand
Execution risk in asset rationalization and potential restructuring charges

Market Snapshot

Exchange

NYSE

Sector

Miscellaneous Chemical Products

Analyst Consensus

8% bullish (12 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3288316

4 reports for CBT

T+1T+5T+20T+60

Filters

Reports for CBT — sortable, filterable
	Type				Now
May 14, 2026 26d ago	8-K NEUTRAL ★ 4/10	$82.09 $78.34	▼ −4.57%	▼ −3.85%	$84.39 (+2.80%)
May 5, 2026 5w ago	8-K MIXED ★ 5/10	$82.41 $84.53	▲ +2.57%	▲ +1.44%	$84.39 (+2.40%)
May 5, 2026 5w ago	Press Release BEARISH ★ 6/10	$82.41 $84.53	▼ −2.57%	▼ −1.44%	$84.39 (−2.40%)
Apr 9, 2026 8w ago	Press Release NEUTRAL ★ 3/10	$74.68 $73.42	▼ −1.69%	▼ −4.87%	$84.39 (+13.00%)

US Market Status

Market Closed — Opens Thu (11h 17m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access